Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery

MLA

Mary Collins, et al. “Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-Envelope Immunity in Lentivector-Based In Vivo Gene Delivery.” Molecular Therapy - Nucleic Acids, vol. 17, Sept. 2019, pp. 126–37. EBSCOhost, https://doi.org/10.1016/j.omtn.2019.05.010.

APA

Mary Collins, Altar M. Munis, Giada Mattiuzzo, Yasuhiro Takeuchi, James E. Eyles, & Emma M. Bentley. (2019). Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-envelope Immunity in Lentivector-Based In Vivo Gene Delivery. Molecular Therapy - Nucleic Acids, 17, 126–137. https://doi.org/10.1016/j.omtn.2019.05.010

Chicago

Mary Collins, Altar M. Munis, Giada Mattiuzzo, Yasuhiro Takeuchi, James E. Eyles, and Emma M. Bentley. 2019. “Use of Heterologous Vesiculovirus G Proteins Circumvents the Humoral Anti-Envelope Immunity in Lentivector-Based In Vivo Gene Delivery.” Molecular Therapy - Nucleic Acids 17 (September): 126–37. doi:10.1016/j.omtn.2019.05.010.